Courtesy of Dr. Carlos Fava. Peripheral vascular disease in lower limbs is on the rise. Antegrade recanalization is associated with amputation and death, and therefore contraindicated. For a while we have been using the retrograde access when classic revascularization is not possible. Even though there is evidence in favor of this access, it is just<a href="https://solaci.org/en/2019/09/11/should-we-start-using-the-retrograte-access-in-critical-limb-ischemia/" title="Read more" >...</a>
Courtesy of Dr. Carlos Fava. The benefit of dual antiplatelet therapy in acute coronary syndromes (ACS) has been proven long ago, and both prasugrel and ticagrelor have offered best results than clopidogrel. However, nowadays, it is unclear which of them is superior in the long term, taking into account the fact that one starts to<a href="https://solaci.org/en/2019/09/05/esc-2019-isar-react-5-which-is-better-in-acs-prasugrel-or-ticagrelor/" title="Read more" >...</a>
After the recent announcement by the US Food and Drug Administration (FDA) green-lighting transcatheter aortic valve replacement (TAVR) in patients across the whole spectrum, and given the advancements regarding devices already in the market (such as MitraClip) and a variety of pulmonary valves, there is only one territory left to conquer: the long forgotten tricuspid<a href="https://solaci.org/en/2019/08/30/physiological-and-clinical-changes-after-tricuspid-repair/" title="Read more" >...</a>
Patients with isolated tricuspid regurgitation (i.e., who have no associated left-sided valve disease) are frequently treated conservatively. In many cases, valve disease is highly symptomatic, even with the optimization of medical treatment; however, an invasive strategy is seldom proposed. The aim of this work was to measure the impact of surgery on isolated tricuspid regurgitation<a href="https://solaci.org/en/2019/08/26/surgery-to-improve-survival-in-isolated-tricuspid-regurgitation/" title="Read more" >...</a>
Angina persistence or recurrence after PCI can affect between 20 to 40% of patients in the short and mid-term. This might be true despite PCI optimization using FFR, intravascular ultrasound and the latest generation stents. This problem is associated with high healthcare cost, which can double in patients with recurrent or persistent angina compared against<a href="https://solaci.org/en/2019/08/22/mechanisms-of-post-pci-persistent-angina/" title="Read more" >...</a>
This year SOLACI celebrated the 10th issue of ProEducar Fellow Course during SOLACI-SBHCI 2019 in Sao Paulo. The course was a roaring success: not only did we have record attendance, with 150 attending fellows, but we also benefited from the participation of notorious international interventionists ─ among others, doctors Stone, Grines, Granada, Hijazi, Abizaid, Mendiz,<a href="https://solaci.org/en/2019/08/13/celebrating-10-years-of-proeducar-fellow-course-with-record-attendance/" title="Read more" >...</a>
The last day of the SOLACI-SBHCI 2019 Congress was full of sessions where different SOLACI areas were widely represented. The first morning session was “From SOLACI to SBHCI // México, Centro América and El Caribe Present: Más Allá de las Coronarias,” which addressed issues related to coronary angioplasty, the importance of imaging in structural procedures,<a href="https://solaci.org/en/2019/08/09/last-congress-day-full-of-solaci-activities/" title="Read more" >...</a>
Prestigious Scientific Societies from all over the world will attend the Congress to discuss the latest advances in interventional cardiology. Discover the International Joint Sessions 01/08 | Paulista Room | 8:30 – 10:00 | Portuguese Society of Cardiology (APIC) Symposium – Acute Coronary Syndrome 8:30 – 8:42 – PCI in NSTEMI ACS: how and when<a href="https://solaci.org/en/2019/07/17/solaci-sbhci-2019-congress-international-joint-sessions/" title="Read more" >...</a>
The II International Symposium on Innovations in the Treatment of Coronary Artery Disease and Structural Heart Disease will take place on July 31st, 2019 at the Syrian-Lebanese Hospital in São Paulo. This event seeks to provide a better understanding of indications and clinical and interventional strategies for complex heart conditions, such as left main coronary<a href="https://solaci.org/en/2019/07/15/ii-international-symposium-on-innovations-in-the-treatment-of-coronary-artery-disease-and-structural-heart-disease/" title="Read more" >...</a>
According to the EXCEL trial, peri-procedural infarction was more common after left main coronary artery surgery compared with angioplasty, and it was strongly associated with increased 3-year mortality after controlling all possible confounding variables. This increased mortality was only present in extensive infarctions with an increase in CK-MB ≥10×. The EXCEL trial seems to want<a href="https://solaci.org/en/2019/07/05/peri-procedural-infarction-in-angioplasty-vs-surgery-in-the-left-main-coronary-artery/" title="Read more" >...</a>